SEZI — Senzime AB (publ) Share News
0.000.00%
- SEK660.30m
- SEK626.74m
- SEK104.02m
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona
Brief: Senzime Q1 Operating Expenses SEK 35.562 Million
Brief: Senzime Wins Expanded Contract Within U.S. Hospital System
Brief: Senzime Secures Strategic Hospital Orders
Sweden's Senzime Q4 sales surge driven by hospital contracts, increased utilization rates
Brief: Senzime Q4 Sales Up At Sek 28.3 Million
Brief: Senzime Secures Credit Line Facility Of 50 Msek
Brief: Senzime Secures Ivy League Hospital System Contract
Brief: Senzime's Next-Gen Tetragraph System Gets Regulatory Approval In Japan
Brief: Senzime Gets Tetragraph Order From UK NHS Hospital System
Brief: Senzime Sees Strong Market Acceptance Of New Tetragraph System
Brief: Senzime Awarded Contract To Supply U.S. Department Of Defense
Brief: Senzime's Tetragraph Is Selected By California University Hospital
Brief: Senzime Secures Tetragraph Installations Across All Sites Of U.S. Hospital System
Brief: Senzime's Tetragraph System Gets Regulatory Approval In Mexico
Brief: Senzime Q2 EBITDA SEK -23.573 Million